Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "NeuroLogica"

150 News Found

CARE Hospitals strengthens advanced cardiac care
Hospitals | June 03, 2026

CARE Hospitals strengthens advanced cardiac care

The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries


National Policy Dialogue adopts landmark 10-point declaration for people with disabilities
Healthcare | June 01, 2026

National Policy Dialogue adopts landmark 10-point declaration for people with disabilities

World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection


International scientists say deuterium research could reshape medicine
R&D | June 01, 2026

International scientists say deuterium research could reshape medicine

The conference highlighted research suggesting that deuterium levels may influence key biological processes


Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
News | May 27, 2026

Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention

Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


Lupin launches Atharv ability neuro-rehabilitation centre in Delhi
News | May 18, 2026

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi

New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches


Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy
News | May 13, 2026

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process


KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru
Hospitals | May 04, 2026

KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru

New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery


KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof


Metropolis Healthcare launches blood-based test for early Alzheimer’s detection
Healthcare | April 27, 2026

Metropolis Healthcare launches blood-based test for early Alzheimer’s detection

New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines